Nucleovir Therapeutics India Pvt. Ltd.
nucleovir.com
Biotechnology
Cell & Gene Therapy
Claim pageClaim
Follow
Overview
Connections
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
1-10
employees, estimated range
Backers
1
Speciale Invest
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
backs AvenCell
Similar startupsby what they do, their industry and backers
Lever Bio aims to translate groundbreaking discoveries in immuno-oncology into next-generation cancer immunotherapies.
Reprogramming is the next leap forward in cancer immunotherapy. Asgard Therapeutics is a Swedish private biotech company exploring direct…
Next generation immunotherapies for hard-to-treat cancers that are allogeneic and switchable.
SAN FRANCISCO, CA [Jan. 28, 2026] – Siren Biotechnology, pioneers of Universal AAV Immuno-Gene Therapy for cancer, today announced that the…
Haptena Therapeutics develops next-generation immunotherapies for oncogene-driven cancers, integrating precision oncology and immune…
Immuneel is advancing access to breakthrough cancer therapies in India, for India and the world.. Cell, gene, and immunotherapies are…
Overview
Nucleovir Therapeutics is an AI-bio immuno-oncology company developing AI-designed, biologically validated cancer immunotherapies.
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Speciale InvestVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Pune
India
HQ
1-10 est. staff
SECTOR 2, PLOT 57, INDRAYANI NAGAR, Bhosarigoan, Pune City, Maharashtra, 411039, IN